EUCTR2004-002823-42-IT进行中（未招募）不适用
A multicentre, double-blind, parallel, randomized, placebo-controlled study Evaluation of the efficacy and safety of Levocetirizine 5 mg and Desloratadine 5 mg administered orally as capsules once daily, in the morning, over 2 weeks in patients suffering from Allergic Rhinitis AR
CB PHARMA0 个研究点目标入组 729 人开始时间: 2006年1月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 729
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A multicentre, double-blind, parallel, randomized, placebo-controlled study :Evaluation of the efficacy and safety of Levocetirizine 5 mg and Desloratadine 5 mgadministered orally as capsules once daily, in the morning, over 2 weeks in patientssuffering from Seasonal Allergic Rhinitis (SAR) due to grass polleAllergic Rhinitis (AR)MedDRA version: 7.1Level: LLTClassification code 10001723EUCTR2004-002823-42-DECB S.A. Pharma Sector729
进行中（未招募）
1 期
Study to evaluate the efficacy and safety of P-3058 10% solution in the treatment of nails affected by fungiEUCTR2015-000561-31-GRPolichem S.A.840
进行中（未招募）
1 期
A multicenter, randomized, double-blind, parallel, three-arm, active- and placebo-controlled therapeutic equivalence for the comparison of clindamycin + tretinoin/Verisfield gel (1+0.025)% with Acnatac®/Meda gel [clindamycin + tretinoin (1+0.025)%] in the treatment of acne vulgarisAcne VulgarisMedDRA version: 20.0Level: LLTClassification code 10000519Term: Acne vulgarisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2022-003070-23-GRVerisfield S.M.S.A.
进行中（未招募）
1 期
Study of safety and efficacy of Hercules versus Herceptin® in patients with breast cancerHuman Epidermal Growth Factor Receptor 2 positive (HER2+) metastatic breast cancer (MBC)MedDRA version: 17.0Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2011-001965-42-BGMYLAN GmbH600
进行中（未招募）
1 期
Study to assess the efficacy and safety of investigational product, P-3074 cutaneous spray, solution, in the treatment of male pattern baldness.Androgenetic alopeciaEUCTR2015-002877-40-DEPolichem S.A.458